Press "Enter" to skip to content

New patent expiration for AGILE drug TWIRLA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for AGILE drug TWIRLA

Annual Drug Patent Expirations for TWIRLA
Annual Drug Patent Expirations for TWIRLA

Twirla is a drug marketed by Agile and is included in one NDA. There are eight patents protecting this drug.

This drug has fifty-six patent family members in twenty-three countries.

The generic ingredient in TWIRLA is ethinyl estradiol; levonorgestrel. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for AGILE drug TWIRLA
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions